US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gene Editing

511.91

+18.153.68%

Number of Gainers:5

Number of Losers:- -

Number of Flat:- -

PE:- -

High:522.02

Open:495.51

Low:495.51

Close:493.76

Loading ...

CRISPR Therapeutics Pick of the Week at Smart Insider Following Simeon George's Stock Purchase

MT Newswires Live

3 Monster Stocks in the Making to Buy Right Now

Crispr Therapeutics AG Stock Soars Amid Insider Confidence

CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares

Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG!

CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares

Crispr Therapeutics AG Stock Soars Amid Strategic Moves

CRISPR Therapeutics (NasdaqGM:CRSP) Advances Cardiovascular Programs With Promising Trial Results

Simply Wall St.

Possible Bearish Signals With Intellia Therapeutics Insiders Disposing Stock

Simply Wall St.

Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4556/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"Gene Editing","latestPrice":511.91302,"timestamp":1753300799999,"preClose":493.7599,"halted":0,"volume":35674037,"delay":0,"changeRate":0.036765,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":18.153137,"latestTime":"07-23 16:00:00 EDT","open":495.50876,"high":522.0232,"low":495.50876,"amount":424774305.271953,"amplitude":0.053699,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753344000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.561757,"peRate":-5.972962,"turnoverRate":0.060648,"increases":5,"decrements":0,"flats":0,"marketCap":10007450584,"floatMarketCap":9652177600},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":522.0232,"amplitude":0.053699,"preClose":493.7599,"low":495.50876,"pbRate":"2.561757","latestPrice":511.91302,"volume":35674037,"delay":0,"open":495.50876,"prevYearClose":376.62552,"prevWeekClose":476.3852,"prevMonthClose":368.039,"prevQuarterClose":368.039,"fiveDayClose":428.2152,"twentyDayClose":361.3764,"sixtyDayClose":329.3158,"secType":"PLATE","market":"US","turnoverRate":0.060648,"peRate":-5.972962,"marketCap":10007450584,"floatMarketCap":9652177600,"timestamp":1753300799999,"nameCN":"Gene Editing"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":5,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553158256","title":"CRISPR Therapeutics Pick of the Week at Smart Insider Following Simeon George's Stock Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2553158256","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553158256?lang=en_us&edition=fundamental","pubTime":"2025-07-22 21:09","pubTimestamp":1753189775,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics  was Smart Insider's stock pick of the week after the company's non-executive Simeon George bought 989,812 shares for $51.5 million on July 16 at $52.03 apiece, while \"more than doubling\" his stake.George bought the shares on behalf of SR One Capital Management, where he is the managing partner, Smart Insider said in a Tuesday note.Their only prior transactions were subscriptions for $931,000 in October 2016 and $75 million in February last year, the note added.\"We are also surprised to see the purchase, assuming the company is in a closed period with their results expected around the 10th of August,\" according to the note.Smart Insider ranked the stock +N, or notable & positive signal, on July 18.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4556","BK4007","BK4539","BK4588","BK4139","BK4611","LENZ","CRSP","MMAT","LU1861559042.SGD","LU1861558580.USD","BK4585"],"gpt_icon":1},{"id":"2553236134","title":"3 Monster Stocks in the Making to Buy Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2553236134","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553236134?lang=en_us&edition=fundamental","pubTime":"2025-07-21 12:07","pubTimestamp":1753070820,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics is still in its early growth stage.Summit Therapeutics has plenty of upside potential remaining.Where can you find the next monster stocks?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/21/3-monster-stocks-in-the-making-to-buy-right-now/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU2362541273.HKD","IE00BLSP4239.USD","LU0266013472.USD","LU0861579265.USD","LU1861558580.USD","LU1941712348.USD","BK4585","LU2089984988.USD","SG9999001176.USD","IE0002141913.USD","IE000M9KFDE8.USD","IE0002270589.USD","LU0965508806.USD","LU1699723380.USD","IE00B19Z3B42.SGD","BK4007","LU1917777945.USD","LU2236285917.USD","LU0106261372.USD","LU1162221912.USD","LU2023250843.SGD","SG9999015341.SGD","LU0203345920.USD","IE00B4R5TH58.HKD","CRSP","IE00BBT3K403.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU1941712264.USD","LU2112291526.USD","LU2324357040.USD","VRTX","IE00BJJMRZ35.SGD","LU1093756168.USD","LU0234572021.USD","IE00BN8TJ469.HKD","LU0965509101.SGD","LU1069347547.HKD","SG9999015358.SGD","LU0823416689.USD","LU0203347892.USD","SG9999002232.USD","LU1066051498.USD","LU1929549753.HKD","IE00B2B36J28.USD","BK4556","MRK","LU2456880835.USD","LU1037948897.HKD","LU0109394709.USD"],"gpt_icon":0},{"id":"2552474414","title":"Crispr Therapeutics AG Stock Soars Amid Insider Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2552474414","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552474414?lang=en_us&edition=fundamental","pubTime":"2025-07-19 22:03","pubTimestamp":1752933802,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 15.44%. Read on to learn why. Crispr Therapeutics AG has seen a notable 15.44% increase in its stoc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-insider-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-insider-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4539","LENZ","BK4007","BK4139","BK4210","BK4585","BK4556","CRSP","BK4611","LU1861558580.USD","AG","LU1861559042.SGD"],"gpt_icon":0},{"id":"2552449489","title":"CRISPR Therapeutics (CRSP) Surges after Director Buys over $51M Worth of Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552449489","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552449489?lang=en_us&edition=fundamental","pubTime":"2025-07-19 00:57","pubTimestamp":1752857833,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics AG ($CRSP) hit a new 52-week high on Friday after an insider bought a large number of shares, which demonstrated that he was ve...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/crispr-therapeutics-crsp-surges-after-director-buys-over-51m-worth-of-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/crispr-therapeutics-crsp-surges-after-director-buys-over-51m-worth-of-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRSP","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4556","BK4588","BK4585"],"gpt_icon":0},{"id":"2552455535","title":"Director Makes Multi-Million Dollar Investment in Crispr Therapeutics AG!","url":"https://stock-news.laohu8.com/highlight/detail?id=2552455535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552455535?lang=en_us&edition=fundamental","pubTime":"2025-07-18 10:04","pubTimestamp":1752804275,"startTime":"0","endTime":"0","summary":"New insider activity at Crispr Therapeutics AG ( ($CRSP) ) has taken place on July 17, 2025. Director Simeon George has made a significant investme...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/director-makes-multi-million-dollar-investment-in-crispr-therapeutics-ag-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/director-makes-multi-million-dollar-investment-in-crispr-therapeutics-ag-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4585","BK4210","BK4588","CRSP","BK4141","BK4556","LU1861559042.SGD","BK4007","BK4611","BK4539","BK4139","LENZ","MMAT","AG"],"gpt_icon":0},{"id":"2552243413","title":"CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2552243413","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552243413?lang=en_us&edition=fundamental","pubTime":"2025-07-18 05:19","pubTimestamp":1752787198,"startTime":"0","endTime":"0","summary":"George Simeon, a Director at CRISPR Therapeutics AG, reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLbCjmgX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"CRISPR Therapeutics AG Director George Simeon Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4588","BK4611","BK4139","LU1861558580.USD","LU1861559042.SGD","BK4585","CRSP"],"gpt_icon":0},{"id":"2550187959","title":"Crispr Therapeutics AG Stock Soars Amid Strategic Moves","url":"https://stock-news.laohu8.com/highlight/detail?id=2550187959","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550187959?lang=en_us&edition=fundamental","pubTime":"2025-07-12 22:04","pubTimestamp":1752329091,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 10.96%. Read on to learn why. Crispr Therapeutics AG has seen a significant boost in its stock pric...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-strategic-moves?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-strategic-moves?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","BK4588","BK4139","LENZ","LU1861559042.SGD","BK4611","BK4210","LU1861558580.USD","CRSP","AG","BK4556","BK4007"],"gpt_icon":0},{"id":"2550663605","title":"CRISPR Therapeutics (NasdaqGM:CRSP) Advances Cardiovascular Programs With Promising Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2550663605","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550663605?lang=en_us&edition=fundamental","pubTime":"2025-07-10 01:54","pubTimestamp":1752083695,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics (NasdaqGM:CRSP) witnessed a substantial price movement, increasing 57% over the last quarter. This significant rise aligns with key developments, such as the company's inclusion in various Russell Indexes, enhancing its market visibility. Concurrently, CRISPR's progress in cardiovascular disease programs with CTX310™ and CTX320™ shows promising clinical trial results, likely fueling investor optimism. Amid a largely flat market, these elements likely contributed to the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-nasdaqgmcrsp-advances-cardiovascular-pro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4082","BK4585","CSII","LU1861558580.USD","LU1861559042.SGD","BK4139","CRSP","BK4556","BK4588","BK4611"],"gpt_icon":0},{"id":"2550654402","title":"Possible Bearish Signals With Intellia Therapeutics Insiders Disposing Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2550654402","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550654402?lang=en_us&edition=fundamental","pubTime":"2025-07-09 23:39","pubTimestamp":1752075563,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) shareholders might have a reason to worry after multiple insiders sold...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ntla/intellia-therapeutics/news/possible-bearish-signals-with-intellia-therapeutics-insiders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861559042.SGD","BK4588","LU1861558580.USD","BK4556","BK4535","NTLA","BK4585","BK4139"],"gpt_icon":0},{"id":"2550572225","title":"Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics today","url":"https://stock-news.laohu8.com/highlight/detail?id=2550572225","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550572225?lang=en_us&edition=fundamental","pubTime":"2025-07-09 08:50","pubTimestamp":1752022208,"startTime":"0","endTime":"0","summary":"20:47 EDT Cathie Wood’s ARK Investment buys 103K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ultimate source for rea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-crispr-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cathie-woods-ark-investment-buys-103k-shares-of-crispr-therapeutics-today-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LU1861558580.USD","BK4611","LU1861559042.SGD","CRSP","BK4539","LENZ","BK4139","BK4007","BK4544","BK4556","ARKK"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}